UK markets close in 2 hours 51 minutes

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.00+0.04 (+0.31%)
At close: 04:00PM EDT
13.00 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
189,590
189,590
172,734
175,601
84,901
Selling general and administrative
64,351
64,351
54,553
40,941
33,886
Total operating expenses
253,941
253,941
227,287
216,542
118,787
Operating income or loss
-253,941
-253,941
-227,287
-216,542
-118,787
Total other income/expenses net
-22,951
-22,951
5,987
51,983
683
Income before tax
-276,892
-276,892
-221,300
-164,559
-118,104
Income tax expense
-601
-601
-469
-297
444
Income from continuing operations
-292,305
-292,305
-237,113
-166,093
-118,548
Net income
-292,191
-292,191
-236,806
-158,725
-117,841
Net income available to common shareholders
-292,191
-292,191
-236,806
-158,725
-117,841
Basic EPS
-4.56
-
-4.48
-3.72
-4.19
Diluted EPS
-4.56
-
-4.48
-3.72
-4.19
Basic average shares
62,234
-
52,857
42,688
28,113
Diluted average shares
62,234
-
52,857
42,688
28,113